Access
This article is part of Nature's premium content.
Published online 8 November 2001 | Nature | doi:10.1038/news011108-10
News
A subset of NSAIDs lower amyloidogenic Aß42 independently of cyclooxygenase activity
Anti-inflammatory drugs stop protein clumps forming in degenerative brain disease.
More evidence is emerging that over-the-counter painkillers such as ibuprofen could form the basis of future treatments for Alzheimer's disease. A new study suggests that some non-steroidal anti-inflammatory drugs (NSAIDs) block a process thought to cause the degenerative brain disease.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
